1.500USD+3.45%Mkt Cap: 22.64M USDP/E: —Last update: 2026-06-01
Apimeds Pharmaceuticals US, Inc. provides digital asset treasury solutions in bitcoin treasury infrastructure. The company was incorporated in 2020 and is based in Matawan, New Jersey. Apimeds Pharmaceuticals US, Inc. op…
Industry Peers
Drug Manufacturers - Specialty & GenericIndicators:|
Key Statistics
Company
Market Cap22.64M USD
Enterprise Value—
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-6.00M USD
Revenue/Share—
Last Price1.500 USD
Fiscal Year End—
MR Quarter—
Employees—
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B2.17
EPS (TTM)-2.78
EPS (Forward)—
52W Range
1.2401% of range40.31
52W High40.31 USD
52W Low1.240 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-3.91%
ROA-3.66%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-8.93M USD
CapEx (TTM)57.33K USD
FCF Margin—
FCF Yield—
Net Debt—
Net Debt/EBITDA—
Balance Sheet
Debt/Equity0.05
Current Ratio—
Quick Ratio—
Book Value/Sh0.6490 USD
Cash/Share—
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:10
Split DateMar 26, 2026
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.15.09M
Float—
Insiders44.55%
Institutions2.97%
Short Interest
Short Ratio0.6d
Short % Float3.39%
Short % Out.1.50%
Shares Short188.11K
Short (prev mo.)92.97K
Technical
SMA 503.756 (-60.1%)
SMA 20015.06 (-90.0%)
Beta—
S&P 52W Chg27.94%
Avg Vol (30d)251.24K
Avg Vol (10d)46.05K
Technical Indicators
RSI (14)35.9
MACD-0.5479
MACD Signal-0.7372
MACD Hist.+0.1894
BB Upper2.340 USD
BB Middle1.578 USD
BB Lower0.8152 USD
BB Width96.66%
ATR (14)0.3517 USD
Vol Ratio (20d)0.03x